382 related articles for article (PubMed ID: 26654098)
21. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.
Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH
Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640
[TBL] [Abstract][Full Text] [Related]
22. Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.
Rådestad E; Sundin M; Törlén J; Thunberg S; Önfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Front Immunol; 2019; 10():189. PubMed ID: 30804948
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T cells in allogeneic hematopoietic stem cell transplantation: From the lab to the clinic.
Gu G; Yang JZ; Zhang JQ; Sun LX
Cell Immunol; 2019 Dec; 346():103991. PubMed ID: 31607390
[TBL] [Abstract][Full Text] [Related]
24. Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
de Witte MA; Sarhan D; Davis Z; Felices M; Vallera DA; Hinderlie P; Curtsinger J; Cooley S; Wagner J; Kuball J; Miller JS
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1152-1162. PubMed ID: 29505821
[TBL] [Abstract][Full Text] [Related]
25. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
26. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
28. Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.
Fuji S; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Choi I; Otsuka E; Henzan H; Kato K; Tomoyose T; Yamamoto H; Kurosawa S; Matsuoka K; Yamaguchi T; Fukuda T
J Clin Oncol; 2016 Oct; 34(28):3426-33. PubMed ID: 27507878
[TBL] [Abstract][Full Text] [Related]
29. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia.
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N
Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567
[TBL] [Abstract][Full Text] [Related]
30. Decreased levels of Th17 cells are associated with invasion fungal infections after allogeneic hematopoietic stem cell transplantation.
Wang L; Zhao P; Shi C; Li Y; Lan K; Han M
Hematology; 2018 Apr; 23(3):148-153. PubMed ID: 28880742
[TBL] [Abstract][Full Text] [Related]
31. Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection.
Ravens S; Schultze-Florey C; Raha S; Sandrock I; Drenker M; Oberdörfer L; Reinhardt A; Ravens I; Beck M; Geffers R; von Kaisenberg C; Heuser M; Thol F; Ganser A; Förster R; Koenecke C; Prinz I
Nat Immunol; 2017 Apr; 18(4):393-401. PubMed ID: 28218745
[TBL] [Abstract][Full Text] [Related]
32. ILCs in hematologic malignancies: Tumor cell killers and tissue healers.
Blom B; van Hoeven V; Hazenberg MD
Semin Immunol; 2019 Feb; 41():101279. PubMed ID: 31200953
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic virotherapy in hematopoietic stem cell transplantation.
Kazemi MH; Kuhestani Dehaghi B; Roshandel E; Parkhideh S; Mehdizadeh M; Salimi M; Hajifathali A; Hamidpour M
Hum Immunol; 2021 Sep; 82(9):640-648. PubMed ID: 34119352
[TBL] [Abstract][Full Text] [Related]
35. [Graft versus host disease and cytokines].
Itoh T
Nihon Rinsho; 2003 Sep; 61(9):1504-11. PubMed ID: 14515716
[TBL] [Abstract][Full Text] [Related]
36. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
Göksoy HS; Arat M
Transfus Apher Sci; 2016 Feb; 54(1):91-8. PubMed ID: 26976480
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
38. New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.
Chang X; Zang X; Xia CQ
Bone Marrow Transplant; 2016 Mar; 51(3):324-32. PubMed ID: 26595077
[TBL] [Abstract][Full Text] [Related]
39. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Yuan X; Sun ZM; Liu HL; Geng LQ; Wang ZY; Tong J; Yao W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):614-7. PubMed ID: 18549640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
